Mirus

MiRus is a pioneering medical technology startup that operates in the cardiovascular and orthopaedic sectors. The company's mission is to improve the lives of patients suffering from these diseases by making surgeries less invasive and implants safer and more durable. MiRus' unique selling proposition lies in its proprietary Rhenium-based alloy, MoRe®, inspired by the material science used in NASA's rocket engines.

This alloy has been developed over 15 years and is used to create innovative implant designs and novel procedural solutions. MoRe® is significantly superior to traditional medical alloys like Titanium and Cobalt Chromium, being stronger, more fatigue resistant, and more biofriendly. It also generates lower levels of metal ions in tissue, reducing potential complications.

MiRus has launched a line of transformational MoRe® implants that are smaller, more durable, and biologically superior to existing options. The company also offers advanced remote monitoring systems to improve patient outcomes over the continuum of care.

MiRus' business model is based on the development and sale of these advanced medical implants and procedural solutions. The company serves a broad range of clients, including hospitals, clinics, and healthcare providers, who are looking for innovative and safer solutions for their patients.

As an early-stage company, MiRus was founded by a team of experienced entrepreneurs with a track record of creating disruptive technologies and highly valued companies. The company offers career development opportunities based on individual strengths and potential, indicating a strong focus on talent acquisition and retention.

Keywords: Medical Technology, Cardiovascular, Orthopaedic, Rhenium-based Alloy, MoRe®, Implants, Procedural Solutions, Remote Monitoring Systems, Early-stage Company, Career Development.